Research context
An experimental peptidomimetic studied in preclinical adipose-tissue models.
Regulatory note: Verify local laws, product approval and professional guidance before any human use. This profile is not a recommendation for use.
Metabolic research
Adipotide
An experimental peptidomimetic studied in preclinical adipose-tissue models.
12 connected records12 graded citations0 external identifiers
Evidence map
Claims linked to original records.
Evidence levels describe study design. They do not by themselves establish safety or effectiveness.
Hossen N, Kajimoto K, Akita H, Hyodo M, Harashima H
A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication.
pubmed
Criscione L
Comment on "a peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys".
pubmed
Barnhart KF, Christianson DR, Hanley PW, Driessen WH, Bernacky BJ, Baze WB, Wen S, Tian M, Ma J, Kolonin MG, Saha PK, Do KA, Hulvat JF, Gelovani JG, Chan L, Arap W, Pasqualini R
A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys.
pubmed
Barnhart KF, Christianson DR, Hanley PW, Driessen WH, Bernacky BJ, Baze WB, Wen S, Tian M, Ma J, Kolonin MG, Saha PK, Do KA, Hulvat JF, Gelovani JG, Chan L, Arap W, Pasqualini R · Science translational medicine
A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys.
pmc
Kirstin F. Barnhart, Dawn R. Christianson, Patrick W. Hanley, Wouter H. P. Driessen, Bruce J. Bernacky, Wallace B. Baze et al. · Science Translational Medicine · 102 citations
A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys
openalex 2011
Md. Nazir Hossen, Kazuaki Kajimoto, Hidetaka Akita, Mamoru Hyodo, Hideyoshi Harashima · Journal of Controlled Release · 55 citations
A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication
openalex 2013
Leoluca Criscione · Science Translational Medicine · 3 citations
Comment on “A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys”
openalex 2012
Frédéric Thuaud, Nigel Ribeiro, Canan G. Nebigil, Laurent Désaubry · Chemistry & Biology · 213 citations
Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential
openalex 2013
Md. Nazir Hossen, Kazuaki Kajimoto, Hidetaka Akita, Mamoru Hyodo, Hideyoshi Harashima · Journal of Controlled Release · 81 citations
Vascular-targeted nanotherapy for obesity: Unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery
openalex 2012
Alexes C. Daquinag, Chieh Tseng, Ahmad Salameh, Y Zhang, Felipe Amaya‐Manzanares, Ali Dadbin et al. · Cell Death and Differentiation · 67 citations
Depletion of white adipocyte progenitors induces beige adipocyte differentiation and suppresses obesity development
openalex 2014
Giacomo Rossino, Emanuela Marchese, Giovanni Galli, Francesca Verde, Matteo Finizio, Massimo Serra et al. · Molecules · 239 citations
Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era
openalex 2023
Daniela I. Staquicini, Sara D’Angelo, Fortunato Ferrara, Katja Karjalainen, Geetanjali Sharma, Tracey L. Smith et al. · The Pharmacogenomics Journal · 29 citations
Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates
openalex 2017
Connected data hub
Records with source provenance.
Reviewed records carry an admin-reviewed badge. Automated records link back to the provider for independent checking.
Article
8 recordsopenalexAutomated import
Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era
Giacomo Rossino, Emanuela Marchese, Giovanni Galli, Francesca Verde, Matteo Finizio, Massimo Serra et al. · Molecules · 239 citations
openalexAutomated import
Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates
Daniela I. Staquicini, Sara D’Angelo, Fortunato Ferrara, Katja Karjalainen, Geetanjali Sharma, Tracey L. Smith et al. · The Pharmacogenomics Journal · 29 citations
openalexAutomated import
Depletion of white adipocyte progenitors induces beige adipocyte differentiation and suppresses obesity development
Alexes C. Daquinag, Chieh Tseng, Ahmad Salameh, Y Zhang, Felipe Amaya‐Manzanares, Ali Dadbin et al. · Cell Death and Differentiation · 67 citations
openalexAutomated import
A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication
Md. Nazir Hossen, Kazuaki Kajimoto, Hidetaka Akita, Mamoru Hyodo, Hideyoshi Harashima · Journal of Controlled Release · 55 citations
openalexAutomated import
Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential
Frédéric Thuaud, Nigel Ribeiro, Canan G. Nebigil, Laurent Désaubry · Chemistry & Biology · 213 citations
openalexAutomated import
Vascular-targeted nanotherapy for obesity: Unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery
Md. Nazir Hossen, Kazuaki Kajimoto, Hidetaka Akita, Mamoru Hyodo, Hideyoshi Harashima · Journal of Controlled Release · 81 citations
openalexAutomated import
Comment on “A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys”
Leoluca Criscione · Science Translational Medicine · 3 citations
openalexAutomated import
A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys
Kirstin F. Barnhart, Dawn R. Christianson, Patrick W. Hanley, Wouter H. P. Driessen, Bruce J. Bernacky, Wallace B. Baze et al. · Science Translational Medicine · 102 citations
Open Access Article
1 recordspmcAutomated import
A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys.
Barnhart KF, Christianson DR, Hanley PW, Driessen WH, Bernacky BJ, Baze WB, Wen S, Tian M, Ma J, Kolonin MG, Saha PK, Do KA, Hulvat JF, Gelovani JG, Chan L, Arap W, Pasqualini R · Science translational medicine
Publication
3 recordspubmedAutomated import
A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication.
Hossen N, Kajimoto K, Akita H, Hyodo M, Harashima H
pubmedAutomated import
Comment on "a peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys".
Criscione L
pubmedAutomated import
A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys.
Barnhart KF, Christianson DR, Hanley PW, Driessen WH, Bernacky BJ, Baze WB, Wen S, Tian M, Ma J, Kolonin MG, Saha PK, Do KA, Hulvat JF, Gelovani JG, Chan L, Arap W, Pasqualini R
Live discovery
Latest research signals
Live results from PubMed, ClinicalTrials.gov and UniProt. These may not yet have been reviewed or stored in the Data Hub.
Recent PubMed records
A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication.PMID 23871959 · 2013 Oct 28Comment on "a peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys".PMID 22539771 · 2012 Apr 25A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys.PMID 22072637 · 2011 Nov 9Registered clinical studies
Reviewed UniProt records
Responsible use of information
Fitzbio provides educational and research reference material. It does not diagnose, prescribe or replace advice from a qualified healthcare professional.